diclofenac has been researched along with Vertigo in 4 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lumiracoxib is as effective as indomethacin for treatment of acute gout and may have a better safety and tolerability profile." | 9.12 | Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. ( Derbot, J; Jung, T; Krammer, G; Kreiss, A; Litschig, S; Mysler, E; Tate, GA; Thurston, H; Willburger, RE, 2007) |
| "The efficacy and tolerability of aceclofenac (100 mg bid; n = 109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n = 110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis." | 9.08 | The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. ( Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A, 1996) |
| "Lumiracoxib is as effective as indomethacin for treatment of acute gout and may have a better safety and tolerability profile." | 5.12 | Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. ( Derbot, J; Jung, T; Krammer, G; Kreiss, A; Litschig, S; Mysler, E; Tate, GA; Thurston, H; Willburger, RE, 2007) |
| "The efficacy and tolerability of aceclofenac (100 mg bid; n = 109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n = 110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis." | 5.08 | The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. ( Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ault, J | 1 |
| Willburger, RE | 1 |
| Mysler, E | 1 |
| Derbot, J | 1 |
| Jung, T | 1 |
| Thurston, H | 1 |
| Kreiss, A | 1 |
| Litschig, S | 1 |
| Krammer, G | 1 |
| Tate, GA | 1 |
| Kornasoff, D | 1 |
| Maisenbacher, J | 1 |
| Bowdler, J | 1 |
| Raber, A | 1 |
| Tausch, G | 1 |
| Eberl, R | 1 |
| Tuschl, P | 1 |
3 trials available for diclofenac and Vertigo
| Article | Year |
|---|---|
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.
Topics: Abdominal Pain; Acute Disease; Administration, Oral; Adult; Aged; Analysis of Variance; Argentina; D | 2007 |
The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; El | 1996 |
[Clinical experiences and results of clinical experimental studies with Voltaren in rheumatic diseases].
Topics: Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Diclofenac; DNA Repair; Drug Evalu | 1976 |
1 other study available for diclofenac and Vertigo
| Article | Year |
|---|---|
Teaching case: migraine and pupil dilation.
Topics: Adult; Anticonvulsants; Comorbidity; Cyclooxygenase Inhibitors; Diclofenac; Female; Fructose; Humans | 2011 |